Tuberculosis : A Global Epidemic

Tuberculosis has long been a disease that the human culture has been dealing with which entails significant morbidity and mortality worldwide. With dealing with such a horrific disease over the years, discoveries and evolution on the appropriate ways to contain, diagnose, and challengingly treat the disease has changed. One of the most concerning complications of this worldwide public health issue is the ability for it to quickly spread in high populated areas while becoming ever more resistant to forms of treatment not available in all locations around the world. This is a serious public

Now, scientists are warning signs of risks of tuberculosis and share information about bacterias and viruses. Today, when a new germ is known, they have a better chance of learning how to cure and fight it. Volunteers take the time to help in laborites in the United States, South America, Central America, and Asia. The World Health Organization reports that third of the world’s population is infected and eight million people get sick from tuberculosis that is identified to be helped by medicine from spreading the disease to

Tuberculosis is a deadly disease that is now affecting our world and the people living in it in a horrible way. Due to many factors such as poverty, HIV/AIDS, and lack of health care, many third world and developing countries have been left very vulnerable to tuberculosis. It is affecting a large part of these countries and is leading them deeper into poverty and sickness. The effort to help these countries against tuberculosis has only been slightly effective against this widespread and destructive disease.

Tuberculosis has been part of human history for a long time but how long is a long time? Recent research using genetic data has allowed us to know that the tuberculosis progenitor has been on this planet for about 3 million years affecting even our earlier ancestors (Gutierrez et al, 2005). Additionally this research showed that the bacilli from tuberculosis are capable of mixing sections of their genome with other strains and giving the pathogen a composite assembly, which resulted from ancient horizontal exchanges before its clonal expansion. This quality provided tuberculosis a big advantage that even now a days allows the organism to evade, adapt and create resistance to treatments that were once successful. In order to fix current and

Tuberculosis is a disease of an infectious nature caused by a bacterium known as mycobacterium tuberculosis. The disease spreads through the air. People with the disease can spread it to susceptible people through coughing, sneezing, talking or spitting. It mainly affects the lungs and other parts such as the lymph nodes and kidneys can also be affected. The symptoms for TB are fatigue, coughing, night sweats, weight loss and fever. One third of the population of the world is affected with mycobacterium tuberculosis. The rate of infection is estimated to be one person per second. About 14 million people in the world are infected with active tuberculosis. Drug resistant TB has been recorded to be a serious public health hazard in many countries. Resistant strains have developed making it difficult to treat the disease. TB has caused millions of death mainly in people living with HIV/AIDS ADDIN EN.CITE Ginsberg19981447(Ginsberg, 1998)1447144717Ginsberg, Ann M.The Tuberculosis Epidemic: Scientific Challenges and OpportunitiesPublic Health Reports (1974-)Public Health Reports (1974-)128-13611321998Association of Schools of Public Health00333549http://www.jstor.org/stable/4598234( HYPERLINK l "_ENREF_3" o "Ginsberg, 1998 #1447" Ginsberg, 1998). The World Health Organization came up with the DOTS (Directly Observed, Therapy, Short course) strategy. The approach involves diagnosing cases and treating patients with drugs for about 6-8

Once believed to be easily treated and prevented, Tuberculosis (TB) has recently been making a steady comeback. Previous to modern medicine, TB claimed millions of victims, spreading from person to person like wildfire. Around the 17th-18th centuries, the “White Plague” took the lives of 1 in 5 adults (20%) in Europe and North America (Iseman, 1994). However, as technological advances progressed, this seemingly ferocious viral disease became a primal, insignificant thing of the past. But, in the nature of all bacteria, TB has, in the recent years, mutated to become progressively drug resistant. Why is Tuberculosis coming back with a vengeance? Well, the answer’s quite simple. TB has done an amazing job of standing in the corner and

Tuberculosis, the white plague as used to be called once upon a time is still one of the deadliest bacterial killers affecting almost all parts, all corners of the globe. Though successful anti-tubercular antibiotic regimens and effective vaccine are available for decades and being used in the battle against Koch’s bacillus, Mycobacterium tuberculosis, the causative agent of this chronic multi organ granulomatous disease, our strand in the battle continuously seems to be in the losing side. Moreover the increasing prevalence of HIV-AIDS and diabetes mellitus is being proved to be providing predisposition to tuberculosis. As witnessed by the WHO, which has estimated that, in the year 2012, 8.6 million people have developed tuberculosis and 1.3 million have died of the disease including 320000 deaths of HIV-TB co-infected people (Global tuberculosis report 2013. World Health Organization; 2013). Long term antibiotic therapy and that too associated with several side effects and discomforts have diminished patient compliance with the anti-tubercular chemotherapy. This fact in turn has raised the new deadlier MDR-TB and XDR-TB strains. The whole scenario is a matter of panic and questioning the effectiveness of anti-tubercular antibiotics, immunologic efficacy of century old BCG vaccine and all other medical advents.

According to the World Health Organization, tuberculosis (TB) is the number two killer worldwide due to a single infectious agent (WHO, 2017). In 2015, 10.4 million new cases have been identified and 1.8 million people have died from this disease (WHO, 2017). TB is caused by the bacteria Mycobacterium TB, and the majority of TB deaths occur in low and middle-income countries. This disease is curable and preventable, but the lack of access to proper healthcare and medication administration makes it a concern for the most of the world’s population. TB is an airborne disease that can transmit when an infected person coughs, sneezes, spits, laughs, or talks. The majority of TB cases can be cured when the right medications are available and

In an era where we consider the improvement of technology as the key to overcoming most a finding of diseases. Tuberculosis disease has been in existence for years; the ancient plague of tuberculosis continues to spread throughout population and countries. Beyond any other infectious disease. “In 2013, 9 million people around the world became sick with TB disease. There were around 1.5 million TB-related deaths worldwide (Kim, Shakow, Castro, Vande, & Farmer, 2015).” With all the technology improvement and drugs we still struggle to manage this deadly disease. Between 18th and19th century tuberculosis spread and reaches its maximal growth in urban and industrial environment of the united states and Europe. During that time in the Western

According to the Centers for Disease Control and Prevention (CDC) in 2014, 9.6 million Americans were infected with the Tuberculosis (TB) disease. Over the years many programs and initiatives have been implemented to decrease the occurrences of TB disease in America. As long individuals are educated on the prevention of tuberculosis fatal complications can be prevented through early treatment. The purpose of this paper is to discuss the description of Tuberculosis and the demographic of interest, determinants of health and how determinants contribute to the development of Tuberculosis, epidemiologic triangle, role of the community health nurse, and the World Health Organization that works to address

Tuberculosis (TB) is the disease of the lung caused by a slow-growing intracellular pathogen called Mycobacterium tuberculosis (M.tb) (1). In 2014, there were 9.6 million cases of active TB disease worldwide, and 1.2 million TB-related deaths according to World Health Organization (WHO) (2). The burden of the disease can be appreciated with the knowledge that one third of the world population is latently infected with M.tb, and 5-10% of exposed individuals develop active disease and are able to spread the infection to more people every year (3,1). To reduce this burden, effective strategies are required in both preventative and therapeutic areas of research.

The Tuberculosis mortality rate has fallen by 45% between 1990 and 2013.(WHO,2014) The overall number of people falling ill with Tuberculosis had started declining and it seems that control was on the right track, i.e. to achieve the Millennium Development Goal to reverse the spread of Tuberculosis by 2015. However two factors threaten to halt the progress made in terms of control of Tuberculosis: Drug Resistance and vulnerability of patients with HIV/AIDS to Tuberculosis. Thus tuberculosis has re emerged in the form of multidrug resistant tuberculosis and Extensively Drug Resistant Tuberculosis.

Tuberculosis is a major pandemic all across the world. It mainly effects the lungs but can spread to other organs. It is a bacterial infection that can be treated. Tuberculosis germs are spread through the air through coughing, sneezing, or spitting. It takes very few of these germs to breathed in to get this disease. About a third of people have latent tuberculosis which is when you have been infected by it but you 're not yet sick. you also can not transmit the disease to other people when you have latent tuberculosis. Millions of lives have been saved by diagnosing on time and correctly treating tuberculosis. Latent tuberculosis is treated by a 9 month one drug treatment while active tuberculosis is treated by a normal 4 drug 6 month treatment. (NA october 2014)

Tuberculosis, also identified as TB, has been around for countless years. In the past, however, the disease was not known, which made it untreatable in most healthcare settings. The evolution of time made it possible to easily detect and manage tuberculosis before people were adversely affected by it. It is a disease that often affects an individual’s lungs, but it can also affect other body parts. The spine, kidneys, bones, and even the lymph nodes may sometimes be affected by the disease. The spread is usually from one person with the disease to an uninfected person through the air. Whenever individuals with the TB disease cough, laugh, or even talk, the disease is spread through tiny droplets that are found in the person’s respiratory

Tuberculosis is among the fatal diseases that are spread through the air. It’s contagious, meaning that it spreads from one infected individual to another, and at times it spreads very fast. In addition to being contagious, the disease is an opportunist infection as it takes advantage of those with weak defense mechanism, and especially the ones with terminal diseases like HIV and AIDS. Tuberculosis is therefore among the major concerns for the World Health Organization due to its contagious nature (World Health Organization 1).